Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-26

Clinical Trial Update: Optimal Doses of Ergocalciferol Supplementation for Treatment of Hypovitaminosis D in Adults [Phase 4]

View source ↗

Summary

An update on a Phase 4 trial evaluating the optimal dosing of ergocalciferol (vitamin D2) for treating hypovitaminosis D in adults; the current study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ergocalciferol (ergocalciferol)

Snippet

Sponsor: Chulalongkorn University | Conditions: Vitamin D2 Supplementation in Vitamin D Insufficiency | Phase 4 | Status: UNKNOWN